Neutrophils are the major type of cell involved in the early stages of many forms of acute inflammation. The neutrophil accumulation in the lung can cause disease by damaging normal host tissue as in the case of adult respiratory distress syndrome (ARDS) 1 (2) , in the inflammation response (asthma, and graft rejection), or in insult as a result of trauma or bacterial infection. Cell surface receptors such as E-selectin (also called ELAM-1; endothelial leukocyte adhesion molecule) belong to a subclass of the IgG superfamily, including VCAM (vascular cell adhesion molecule) and ICAM (intercellular adhesion molecules 1, 2, and 3). E-selectin reacts with a fucosylated carbohydrate residue on the neutrophil (3), whereas the leukocyte integrins containing the CD18 antigen react with ICAM-1. The expression of E-selectin and ICAM-1 is induced by cytokines produced at the site of inflammation. This serves to enhance neutrophil adherence to endothelial cells and migration from the circulation into extracellular tissues at these sites. Neutrophils contribute further to the inflammatory process by releasing tissue-damaging mediators.
E-selectin is a member of the selectin gene family. Each of these proteins is composed of an amino-terminal lectin domain followed by an epidermal growth factor-like (EGF) domain, five complement regulatory repeat units, a single membrane-spanning region and a carboxyl-terminal cytoplasmic domain. The lectin and the EGF domains are both necessary and sufficient to mediate neutrophil adhesion (4) . The three-dimensional structure of the lectin/EGF domains that includes the ligandbinding region has been reported for this molecule (1) . A specific surface region of the lectin domain of E-selectin that contains a loop between ␤-strands ␤ 4 and ␤ 5 with exposed Tyr-94 and Arg-97 side chains has been implicated in ligand binding based on the structural and related biochemical studies (1) .
Antibodies and antibody fragments specific for the cell-surface receptors have the potential for modulating the interaction of neutrophils with endothelial cells, and hence, the inflammatory response. A monoclonal anti-ICAM-1 antibody R6.5, that inhibits the attachment of neutrophils to endothelium and also prevents the attachment of major group human rhinovirus (HRV) to ICAM-1, has been reported (5) . Recently, the structure of the Fab fragment of this antibody was reported at 2.8 Å resolution (6) . The surface contour of the antigen-combining site of this molecule has a groove that resembles more the * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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structure of an antipolypeptide antibody than the structure of an antiprotein antibody.
Another potent blocking antibody directed at a cell surface receptor, E-selectin in this case, has been raised. This antibody binds to the lectin/EGF domain of E-selectin. 2 We report here the primary and three-dimensional structures of the Fab fragment determined by automated Edman degradation analysis of proteolytic fragments of the heavy and light chains of the antibody and by x-ray crystallographic techniques at 2.8 Å resolution, respectively. The analysis of the structural studies of the anti-E-selectin 7A9 Fab presented here focuses on the complementary determining regions and the comparison with the three-dimensional structures of an anti-ICAM Fab and the anti-human rhinovirus Fab.
EXPERIMENTAL PROCEDURES
Antibody Production-The perfusion system used was a 50-liter stirred tank bioreactor utilizing an external rotating filter. SP-20 fusion mouse-mouse hybridoma cells were cultured in a medium with a protein-free formulation, and 0.1% Pluronic F-63 (Sigma) was added for shear protection. The cell densities were maintained at 1 ϫ 10 7 viable cell counts/ml and perfusion-adjusted to keep nutrients (glucose, etc.) and metabolites at the appropriate levels. Ion exchange and affinity chromatography were used to purify the antibody.
Generation and Purification of F(abЈ) 2 -The conversion of 7A9 antibody to F(abЈ) 2 was accomplished by incubating the IgG1 with pepsin (E:S of 1:100) for 2 h at 37°C, after adjusting pH to 3.5 using 1.0 M citrate buffer. The digestion products were subjected to cation-exchange chromatography in an S-Sephacryl fast flow column, using a linear sodium chloride gradient (0.1-0.5 M) in 20 mM acetate buffer, pH 5.0, as eluant. F(abЈ) 2 eluted as a single peak with purity greater than 97%, as judged from SDS-polyacrylamide gel electrophoresis analysis (results not shown).
Flow Cytometry Analysis-Titration analysis of the intact antibody and of the F(abЈ) 2 was performed using a Coulter FACS Elite Analyzer. Samples for the flow cytometry analysis of endothelial cells (human umbilical vein endothelial cell, HUVEC) included stimulation with and without interleukin-1␤ (IL-1␤). This assay measures the number of cells that shift to greater fluorescence intensity after specific binding (positive response). In this analysis, the intact 7A9 antibody and the F(abЈ) 2 fragment showed comparable binding efficiency to the surface of HUVEC cells on a molar basis, indicating that the digestion with pepsin did not affect its binding ability (Fig. 1A) .
Biological Activity-Biological activity was based on inhibition of HL60 (a myeloid leukemia line from ATCC) binding to soluble Eselectin assay (7) . Ten g/ml of the 7A9 antibody F(abЈ) 2 fragment were added in wells, followed by 51 Cr-labeled HL60 cells (10 5 /well) and incubated for 30 min at 22°C in a static adhesion assay. Nonadherent cells were removed by rinsing with 1% bovine serum albumin in 0.1 M phosphate-buffered saline, and the residual activity in the wells was measured in a ␥ counter. The details of the assay have been previously described (8) . Fig. 1B shows that the anti-E-selectin antibody F(abЈ) 2 fragment is inhibitory to granulocyte binding to HL60 cells in a dosedependent manner.
Primary Structure Determination-The amino acid sequences of the F(abЈ) 2 heavy and light chains were determined after separating both chains of the reduced, alkylated intact 7A9. The samples were reduced with dithiotreitol, alkylated with vinylpyridine or iodoacetamide, and purified by reverse-phase high performance liquid chromatography. Each purified chain was subjected to automated Edman degradation analysis. Additionally, a reduced alkylated sample from purified F(abЈ) 2 was digested with Lys-C protease, and the resulting fragments were separated by reverse-phase high performance liquid chromatography using a C-18 column. The amino acid sequences of the purified peptides were determined by using a protein microsequencer (ABI, Model 477-A) coupled to an on-line PTH-Analyzer (Model 120-A) and a 900-A data reduction module. Digestion with Lys-C protease resulted in 26 peaks for the heavy and light chains of an Fab fragment (chromatogram not shown). Fig. 2 shows the complete amino acid sequence for each of the peaks in the heavy and light chains of the fragment. The sequences of the two chains are consistent with that of the IgG1 class with an associated light chain. Both the heavy and light chains have two intra-chain disulfide bridges. The sequences of the six CDRs are indicated in Fig. 2 .
Crystallization-The F(abЈ) 2 was incubated before the crystallization trials with dithiotreitol for 19 h at a ratio of 2:1 (w/w). The initial crystallization trials were performed using a "fast screen" approach (9) employing the Hampton Research Crystal Screen kit (10) . Experiments were set up using the hanging drop vapor diffusion method (11) . For the screen, the crystallization drops were prepared by mixing 3 l of a solution containing 9.6 mg/ml protein in 10 mM HEPES/HCl at pH 7.0 with an equal volume of the reservoir solution. Initially, small crystals appeared in droplets equilibrated against well solutions containing 0.2 M (NH 4 ) 2 SO 4 , 0.1 M sodium cacodylate, 30% (w/v) PEG8k at pH 6.5. Refinement of the crystallization conditions was performed using sitting drop vapor diffusion experiments (12) . The final reservoir solution consisted of 0.2 M (NH 4 ) 2 SO 4 , 0.1 M sodium cacodylate, and 20% (w/v) PEG8k at pH 6.5. Crystals appeared within 3 days at room temperature and grew to full size within 2 weeks (typical dimensions of 0.2 ϫ 0.3 ϫ 0.7 mm 3 ). X-ray Data Collection and Processing-The diffraction data were collected at room temperature using a Siemens electronic area detector. This detector was mounted on a Rigaku RU-200 generator operated at 40 kV, 60 mA with a 0.3-mm focal spot. A graphite monochromator followed by a 0.5-mm collimator was used. During data collection, the area detector was mounted 16 cm from the crystal and 2 was 16°. Diffraction data collected with the area detector were electronic images, 2 W. Newman, unpublished observation. X-ray Structure Determination and Refinement-The structure of the 7A9 Fab fragment was determined by molecular replacement (15) followed by iterations of expanding and adjusting the model to fit the electron density map and refining the structure. The molecular replacement and refinement calculations employed the X-PLOR program package (16) . All the model building and correction procedures were carried out using the program QUANTA Version 4.1.1 (Molecular Simulations Inc., Burlington, MA).
The search model used in the molecular replacement calculations was based on the crystal structure of the Fab 8F5 that neutralizes human rhinovirus serotype 2 (Protein Data Bank code 1BBD) (17) . This Fab has a high percentage of sequence identity with the 7A9 Fab, 96% for the light chain and 83% for the heavy chain, although its elbow bend angle is the smallest reported to date (127°). The search probe was constructed by truncating the side chains at the CB or CA atoms for all corresponding residues that were different between the 8F5 and the 7A9 Fabs.
The rotation search was done using the intact probe with variable "elbow bend" angles between variable (V) and constant (C) domains ranging from 127°to 167°(16). The largest peak in the rotational function search was 6 above background at the Eulerian angles ␣ ϭ 94.1°, ␤ ϭ 15.0°, and ␥ ϭ 314.1°. The Patterson correlation refinement of the rotation function peak gave final angles of ␣ ϭ 93.5°, ␤ ϭ 16.2°, and ␥ϭ315.7°, with a correlation coefficient of 0.018. The solution was obtained at an elbow angle of 162°. Using this rotation function solution, the translation function search produced a solution at x ϭ 8.9, y ϭ 25.1, and z ϭ 57.9. It was 8.5 above the background and 2.2 above the next highest peak. The application of the rotation and translation solutions to the probe molecule gave a crystallographic R (R ϭ ⌺͉F o Ϫ F c ͉/⌺F o , summed over all h, k, l indexes) value of 0.49.
The molecular replacement solution was subjected to rigid body refinement using 8 -4 Å data with an overall temperature factor of 15 Å 2 . Each of the four domains, V H , C H , V L , and C L (variable and constant domains of heavy and light chains), was allowed to move independently to correct the position of the molecule in the unit cell. After this, R was reduced to 0.38. Next, a positional refinement followed by simulated annealing with a slow-cooling protocol (18) was carried out using data between 8.0 and 2.8 Å. The Engh and Huber (19) geometric parameters for amino acid residues were used as the basis of the protein force field. At this point, map fitting, using 2F o -F c and F o -F c maps, was used to expand the model to include omitted residues and side chains. Two additional cycles of simulated annealing refinement and map fitting were then carried out. At this stage, residues His 136 -His 140 and 45% of the residue side chains were included, reducing the R factor to 0.206. Then an overall temperature factor was refined followed by group temperature factor refinement for each amino acid residue. A number of cycles of map fitting followed by stereochemical restrained least squares refinement were carried out to complete the structure determination producing a final crystallographic R factor of 0.195. A summary of the data collection and refinement statistics is presented in Table I . Ten water molecules were included in the model.
Structure Analysis and Comparison-Analysis of the stereochemistry of the intermediate and final models was done using the PRO-CHECK program package (20) . The molecular comparisons were carried out with the ALIGN program (21) using only the CA atom positions of the polypeptide backbone. Surface curvature and electrostatic calculations were performed using the program GRASP (22) .
RESULTS AND DISCUSSION
Molecular Structure-The tertiary and quaternary structure of this molecule is consistent with all the crystallographically determined Fab structures. It presents an elbow angle (between the pseudodyad axes relating the V and C domains of the two chains (23)) of 162°, 35°larger than the search model (Fig.  3) -Cys 199 ). The final coordinates of the Fab fragment consist of 437 amino acid residues, 220 residues for the light chain fragment and 217 residues for the heavy chain. cis-Proline residues occur at positions 8, 101, and 147 of the light chain and positions 154 and 156 of the heavy chain (residue numbering refers to Fig. 2) . The final 2F o -F c electron density map, contoured at 1 , shows good overall agreement with the structure. The electron density map corresponding to the L3 CDR is shown in Fig. 4 . The hydrophobic core of the subunits as well as the interfaces between heavy and light chains are in strong, continuous electron density. The regions of the map corresponding to the CDR loop regions are also well defined except for residues 100 -104 at the tip of the H3 CDR loop, where weak density is observed (these residues have been omitted from the final model). Also, the electron density for the distal extremity of the constant region, in particular residues 138 -140, is ill defined, and their conformation must be considered as tentative. Side chains of residues 17 and 114 of the light chain and 13, 105, 139, 140, and 194 of the heavy chain show poorly defined electron density and were therefore not modeled beyond CB.
The root mean square deviations of coordinates from the stereochemical standards on both bond lengths and angles were 0.015 Å and 2.1°, respectively, and the average temperature factor is 15 Å 2 . The Ramachandran plot (24) indicates that the main-chain torsion angles (⌽ and ⌿) fall within the energetically favored regions, except for Ala 57 of the light chain, that is located in the L2 CDR. This constrained conformation has been reported to occur in other proteins, specifically at the active site (25) . The geometry of the side chain dihedral angles was also examined. Nearly all values lie in the expected regions. An analysis of the structure shows that almost 80% of the 437 residues with side chain dihedrals adopt preferred rotamer conformations.
Overall, the heavy chain residues have higher average temperature factors than the light chain residues. The variations of residue-averaged temperature factors follow closely the alternating ␤-strands and loops along the polypeptide chain. The loops at the end of the constant region exposed to the solvent and essentially not involved in crystal packing interactions appeared more flexible, with large temperature factors. The highest B factors are in the solvent exposed loop areas indicating their flexibility and/or partial disorder.
At the carboxy ends of both light and heavy chain are regions of unexplained non-continuous density. This could be the result of pepsin digestion and dithiothreitol treatment, indicating different species with different lengths for the carboxy end of the heavy chain.
The Antigen Combining Site-The most interesting feature of the structure is the surface of the antigen combining site that presents an irregular concave surface (Fig. 5) . Currently it is known that five out of the six hypervariable loops that form the antigen-binding site are limited to a few main-chain conformations (canonical) (26) . These conformations can be predicted by the size of the CDR and the occurrence of a specific set of residues that produce a known conformation. Recent studies (27) indicate that antibodies exhibit a surprisingly small number of combinations of canonical structures. Moreover, it has been shown (28) that the shapes allowed by these combinations correlate, in some cases, with the type of antigens with which the antibody interacts. Four different groups of antibody-antigen topographies have been distinguished: concave (for small haptens), moderately concave, grooves (for peptides and carbohydrates), and planar (for proteins).
The CDRs of 7A9 are canonical: the L1 CDR belongs to the canonical group 3, the L2 CDR to group 1, the L3 CDR to group 1, the H1 CDR to group 1 and the H2 CDR to group 2. No canonical groups have been identified for the H3 CDR (29) . Then it belongs to the class 1-2-3-1-1. Major conclusions drawn from the analysis of the surface of the combining site are that this antibody displays a groove found at the interface between the heavy and light chain variable domains and that L1 CDR points out into the solvent (Fig. 5) . Residues from the six CDRs and framework residues form the floor and walls of the groove. This groove is approximately 22 Å wide and 8 Å deep, and it is lined with many aromatic residues. It is worth mentioning that 8F5 is the only antibody of known three-dimensional structure, that belongs to the same canonical class, 1-2-3-1-1, and displays a similar groove in the combining site (17) . This type of topography has been observed for peptide binding antibodies
Since the lectin activity of E-selectin is abolished when it combines the 7A9 Fab, it is possible that the loop containing the amino acid residues that are essential for the activity (Tyr 94 and Arg 97 ) could partially fit this Fab groove at the combining site. Similar topography has been observed also for other antireceptor antibodies, like the anti-ICAM-1 antibody (6), or those that bind peptides, in particular peptides that adopt a ␤-turn conformation (30) .
Comparison of Anti-E-selectin, Anti-ICAM, and Anti-human Rhinovirus Fabs- Fig. 5 shows the CA superposition for the variable fragments (Fv) of the three antibodies, 7A9, and R6.5 (Protein Data Bank code 1RMF) (6) directed against cell receptors E-selectin and ICAM-1, and the Fv of the anti-human rhinovirus 85F (Protein Data Bank code 1BBD) (17) , used for the molecular replacement analysis. The combining sites of 7A9 and 8F5 belong to the same canonical class, while R6.5 has an extra residue in the L1 CDR and belongs to class 1-2-4-1-1. Structurally it is clear that these Fv fragments are remarkably similar. For the V L domain, the main differences can be appreciated in the L1 CDR loops, due mainly to differences in length. However, in the three structures, this loop is pointing into the solvent. A greater variation is observed for the V H domain. At this stage of the refinement, we cannot conclude anything concerning H3 CDR because we could not find clear density for the five residues at the tip of the loop. On the other hand, this is the most variable loop among antibodies.
The conformation of H2 CDR is very similar for 7A9 and 8F5; however, R6.5 shows a conformation not observed before for this type of region. It is possible that this loop had been incorrectly built (31) . Evidently, the topology of the binding site is approximately the same, despite some slight differences in the conformation of some loops. To stress this fact, the molecular surface of 7A9 and R6.5 Fabs is shown in Fig. 6 . Clearly, both antibodies present a groove at the antigen binding site.
Conclusions-The feature most frequently observed in antibody-peptide complex structures is a ␤-turn in the peptide that is embedded in the antibody-antigen interface. Several examples of this recognition motif have been described to date and include a type I ␤-turn, reported for the VP2 peptide in complex with 8F5 (32) and a type II ␤-turn for the HIV-1 peptide (gp120) in the 59.1 complex (33). Shoham (30) had suggested that antipeptide antibodies seemed to induce a ␤-turn conformation in the bound peptide, irrespective of the peptide sequences. However secondary structure predictions for the sequences have shown that they have a tendency to form the turn types found in the Fab-peptide structures. Therefore, it would be expected for these peptides to mimic their protein counterparts (30, 34, 35) . In 1995, Tormo et al. (36) reported a model for 8F5 IgG docked onto the viral surface through the peptide in VP2, which adopted the same conformation. On the other hand, Jedrzejas et al. (6) proposed that R6.5 could bind ICAM-1 through a ␤-turn in domains D1 or D2.
The antigen combining site of 7A9 is consistent with those observed for Fab directed against proteins that have epitopes that adopt a loop conformation. It is very possible that 7A9 antibody could bind the loop connecting ␤ 4 and ␤ 5 on the lectin domain of E-selectin, which contains the two residues essential for neutrophil adhesion (1) . Docking experiments of 7A9 Fab fragment and the lectin/EGF domains of E-selectin are now in progress. Oligopeptide libraries are also being tested for this antibody.
